| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT05486234 CARS: Cannabis and Alcohol Reduction Study |
date change Primary completion pushed: 2026-07-31 -> 2026-09-30 |
| 2026-08-14 | NCT05486234 CARS: Cannabis and Alcohol Reduction Study |
date change Completion pushed: 2026-08-01 -> 2026-10-01 |
| 2026-08-14 | NCT05064319 Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis… |
Trial completed |
| 2026-08-14 | NCT05064319 Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis… |
Enrollment reduced: 68 -> 51 participants |
| 2026-08-14 | NCT06616831 At-Home taVNS - Stroke Rehab |
Trial completed |
| 2026-08-14 | NCT06616831 At-Home taVNS - Stroke Rehab |
Primary endpoint(s) modified |
| 2026-08-14 | NCT06616831 At-Home taVNS - Stroke Rehab |
date change Primary completion moved earlier: 2026-09-30 -> 2025-03-26 |
| 2026-08-14 | NCT06616831 At-Home taVNS - Stroke Rehab |
date change Completion moved earlier: 2026-09-30 -> 2025-03-26 |
| 2026-08-13 | NCT06862622 Neural Representations of Memory Transformation (MEM_TRANS) |
date change Primary completion pushed: 2026-09-30 -> 2027-09-30 |
| 2026-08-13 | NCT06862622 Neural Representations of Memory Transformation (MEM_TRANS) |
date change Completion pushed: 2026-09-30 -> 2027-09-30 |
| 2026-08-13 | NCT07689773 Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label |
Recruitment opened |
| 2026-08-13 | NCT07503782 OEA for Young Adults With Alcohol Use Disorder |
date change Primary completion pushed: 2031-03-31 -> 2031-06-01 |
| 2026-08-13 | NCT07503782 OEA for Young Adults With Alcohol Use Disorder |
date change Completion pushed: 2031-03-31 -> 2031-06-01 |
| 2026-08-13 | NCT05725239 taVNS or TMS or Both for Depression |
date change Primary completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-08-13 | NCT05725239 taVNS or TMS or Both for Depression |
date change Completion pushed: 2026-07-01 -> 2027-07-01 |
| 2026-07-28 | NCT04523922 Oxytocin to Enhance Integrated Treatment for AUD and PTSD |
Trial completed |
| 2026-07-28 | NCT04523922 Oxytocin to Enhance Integrated Treatment for AUD and PTSD |
date change Primary completion moved earlier: 2026-06-01 -> 2026-04-13 |
| 2026-07-28 | NCT04523922 Oxytocin to Enhance Integrated Treatment for AUD and PTSD |
date change Completion moved earlier: 2026-12-01 -> 2026-04-13 |
| 2026-07-23 | NCT05349682 Bayer OA Knee Pain Pilot |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-07-23 | NCT05349682 Bayer OA Knee Pain Pilot |
date change Completion pushed: 2026-06 -> 2026-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-10 | NCT07754578 DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use Pharmacotherapy | Phase 2 | Not Yet Recruiting |
| 2026-08-03 | NCT07743190 A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant… | Phase 2 | Not Yet Recruiting |
| 2026-08-03 | NCT07743229 COG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints | Not Yet Recruiting | |
| 2026-07-22 | NCT07720167 Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer | Phase 2 | Not Yet Recruiting |
| 2026-07-22 | NCT07720180 Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07213544 | Remimazolam vs Propofol in Laser Burn Cases | Burn Scar | Recruiting |
| NCT06748209 | Establishing Mobile Transcranial Magnetic Stimulation | Treatment Resistant Major Depression | Recruiting |
| NCT06688539 | E-cigarette Cessation in Adults Who Co-use Cannabis | Nicotine Dependence | Recruiting |
| NCT06144177 | Induction in the Dark | Anesthesia Induction | Recruiting |
| NCT06824649 | Biologics in Chronic Rhinosinusitis With Nasal Polyposis | Chronic Sinusitis | Recruiting |
| NCT06951906 | Imaging Biomarkers of FOG Response to DBS | Freezing of Gait Symptoms in Parkinson's Disease | Recruiting |
| NCT04482673 | Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection | COVID-19 | Active, Not Recruiting |
| NCT07448597 | Progesterone Preeclampsia | Preeclampsia | Not Yet Recruiting |
| NCT07625956 | Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for… | Smoking ( Cigarette) | Enrolling by Invitation |
| Phase 3 | |||
| NCT06039566 | NAC vs Placebo on Opioid Use for Hysterectomy | Hysterectomy | Recruiting |
| NCT07226076 | Methadone in TKA for Post-op Pain and Opioid Reduction | Post Operative Pain | Recruiting |
| NCT07227064 | Methadone in THA for Post-op Pain and Opioid Reduction | Post Operative Pain | Recruiting |
| NCT06883162 | Cannabis-Tobacco Co-Use Treatment Study | Tobacco Use Disorder | Recruiting |
| Phase 2/3 | |||
| NCT07049952 | BabySTrong II taVNS Feeding Trial | Feeding Delays | Recruiting |
| NCT05855369 | Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) | Smell Dysfunction | Recruiting |
| Phase 2 | |||
| NCT06971744 | Autophagy Maintenance (AUTOMAIN) | Ovarian Cancer | Recruiting |
| NCT07022418 | Formoterol in Diabetes | Diabetic Nephropathies | Recruiting |
| NCT07227610 | Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT) | Brain Metastases | Recruiting |
| NCT07325721 | Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced… | Prostate Cancer | Recruiting |
| NCT05586360 | T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use… | Prostate Cancer | Recruiting |
| NCT04861064 | Weekly Sirolimus Therapy | Venous Malformation | Recruiting |
| NCT06424067 | Phase 2 Study of Fingolimod in Lung Cancers | Non Small Cell Lung Cancer | Recruiting |
| NCT06905132 | Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma | Soft Tissue Sarcoma | Recruiting |
| NCT06845319 | NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast… | Triple Negative Breast Cancer | Recruiting |
| NCT07076212 | Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients… | Metastatic Pancreatic Adenocarcinoma | Recruiting |